Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05589935 · ClinicalTrials.gov registry record · NA

Radicle Relief 1: A Study of Health and Wellness Products on Pain and Other Health Outcomes

A NA study of Pain and Neuropathic Pain, sponsored by Radicle Science.

Completed
Registry status
NA
Development phase
457
Enrollment target
1
Study location

NCT05589935: Completed NA study of Pain and Neuropathic Pain, sponsored by Radicle Science.

NCT05589935 is a NA study of Pain and Neuropathic Pain that has completed, run by Radicle Science. The registered enrollment target is 457 participants, above the 303-participant average among 374 other Pain trials with a reported enrollment target (51% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05589935, a NA study of Pain and Neuropathic Pain, has completed, sponsored by Radicle Science.

COMPLETED
Registry status
NA
Development phase
457 participants
Enrollment target
1
Study location

Study Summary

A randomized, blinded, placebo-controlled study assessing the impact of health and wellness products on pain and other health outcomes

Primary Outcome

Mean difference in pain interference score as assessed by Patient Reported Outcome Measurement System (PROMIS) Pain Interference 6A \[scale 6-30; with higher scores corresponding to greater pain interference\]

Interventions

  • DIETARY_SUPPLEMENT Relief Study Product Usage

Study Locations (1)

California

  • Radicle Science, Inc - Del Mar

Trial Details

FieldValue
Enrollment Target 457 participants
Start Date 2022-11-22
Est. Completion 2023-05-24
Phase NA
Radicle Science

55 total trials

What the finished NCT05589935 record still lists

NCT05589935 is an interventional study that assigns participants to a tested intervention. The registered 457 participants enrollment target is mid-sized for trials with a published cap, above the 303-participant average among 374 other Pain trials with a reported enrollment target (51% higher).

The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Relief Study Product Usage is the first listed.

NCT05589935 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05589935 about?

NCT05589935 is a clinical study titled "Radicle Relief 1: A Study of Health and Wellness Products on Pain and Other Health Outcomes". A randomized, blinded, placebo-controlled study assessing the impact of health and wellness products on pain and other health outcomes

What is the current status of trial NCT05589935?

This trial is currently completed. It is a NA study. The enrollment target is 457 participants. The study started on 2022-11-22. Estimated completion is 2023-05-24.

What conditions does trial NCT05589935 study?

This clinical trial studies the following conditions: Pain, Neuropathic Pain, Nociceptive Pain.

What interventions are being tested in trial NCT05589935?

The interventions under investigation include: Relief Study Product Usage (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05589935?

This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05589935 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05589935's enrollment target sits among peer trials

457 39th of 374 higher than 336 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05856942 · 458 participants · NA

    Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program

  • NCT06201676 · 458 participants · Phase 4

    Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients

  • NCT04462302 · 456 participants · NA

    An Internet-based Program to Help Cancer Survivors Manage Pain

  • NCT05820919 · 456 participants · NA

    Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05589935, the US trial registry maintained by the National Library of Medicine. NCT05589935 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.